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Abstract
Liver transplantation has become a victim of its own success in that there are no longer enough
suitable livers for transplantation while at the same time the indications for transplantation increase.
Efforts to expand the number of recipients who benefit from this life-saving procedure are being
made, in particular through the use of split grafts and live donors. However, such grafts are associated
with increased morbidity and mortality related to their reduced size.
Introduction and context
Liver transplantation is currently the treatment of choice
for end-stage liver disease, including acute liver failure
and some metabolic disorders [1]. However, there is a
mismatch between potential recipients requiring trans-
plantation and the availability of suitable livers, resulting
in the deaths of patients on the waiting list. This has been
compounded by a broadening in the accepted indica-
tions for transplantation despite reductions in those
transplanted for chronic viral hepatitis [2]. For example,
it has been shown that older recipients and those with
other medical problems such as obesity can also do well
and benefit from transplantation [3]. A further com-
pounding factor has been a reduction in cadaveric
donors from road traffic accidents as road safety has
improved over the last 20 years. Accommodating this
increase in potential recipients requires an increase in the
donor pool and methods to achieve this include the use
of split livers, in which one liver is used for two
recipients, and live donation.
Recent advances
Surgical splitting of a graft allows one liver to be used for
two recipients. The increased surgical expertise such
techniques demand has contributed to the increasing use
of live donation of a partial liver graft. Split liver
transplants (SLTs) conventionally generate an extended
right graft consisting of segments I and IV-VIII suitable
for transplantation in adults and a left lateral graft of
segments II and III for use in a child. The use of SLT and
live donation has greatly reduced mortality of children
waiting for liver transplantation. One limiting factor in
SLT and live donation is the size of the graft for adult
recipients. In SLT, a full right (segments V-VIII) and full
left (segments I-IV) can be created but often are not
adequate in size for two adult recipients. If the graft is too
small for the recipient, the metabolic demands for the
individual are not met and small for size syndrome
(SFSS) develops. This can be seen after both cadaveric
and live donations. SFSS is characterised as the triad of
postoperative ascites, cholestasis, and coagulopathy [4],
which is associated with increased mortality. Small for
size can be determined as either a graft weight/recipient
weight ratio of less than 0.8% [5] or a graft volume/
standard liver volume ratio of less than 40% [6].
Increased understanding of SFSS has led to the recogni-
tion that factors other than size, in particular the graft
haemodynamics and quality, contribute to SFSS [7].
Portal hyperperfusion and impaired drainage in small
grafts contribute significantly to SFSS and can be
modulated to reduce portal venous inflow and ensure
adequate outflow (Table 1), thereby allowing the safe
transplantation of smaller grafts [8]. Even in cases in
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splenic artery occlusion can be performed either at
reoperation or radiologically with improvement in graft
function [9].
Another approach to overcome the size issue is the use of
left lateral segments from two different donors. This has
been pioneered in Seoul to ensure adequate hepatic
volume to the recipient [10,11]. It may be useful in
situations in which the donor left lateral segments are
insufficient to meet the demands of the recipient and the
donation of the right hemi-liver would leave the donor
with an insufficient residual liver volume. This does
increase the risk of performing a procedure to two
otherwise healthy donors. Alternatively, left lateral
segments from a living donor can be transplanted
together with the left segments from a caderveric donor
(with the right-side graft used on its own in another adult
recipient); however, there are significant logistical
barriers [12].
Auxiliary liver transplantation is another method in
which small grafts may be used. The recipient’s native
liver is left in situ either completely or partially, and
usually a reduced graft is transplanted orthotopically
(due to inferior outcomes from heterotopic transplanta-
tion [13]). This has been used primarily in acute liver
failure as a means to provide time for the recipient’s own
liver to recover [14]. Following recovery, the graft may be
removed or alternatively immunosuppression may be
stopped.
The main technical consideration with auxiliary grafts
is haemodynamic, with circulatory competition between
the graft and native liver. To improve the circulation
in auxiliary liver transplantation, reno-portal anastomo-
sis that avoids disturbing the vasculature to the native
liver has been described [15]. Remarkably, in some
cases, the auxiliary graft has been successfully retrans-
planted to another recipient following recovery of the
native liver [16].
Implications for clinical practice
With increased understanding of the factors associated
with SFSS, it is possible to use smaller grafts in recipients
with acceptable outcomes, especially where there is a
shortage of suitably donated organs. This has special
pertinence in live liver donation, in which there is a real
risk of causing severe morbidity and mortality in a
healthy individual. Due to the size factor, the larger right
hemi-liver may be donated to larger recipients. However,
this has an increased risk compared with left-sided
donations and has resulted in at least three reported
cases in which donors have subsequently required liver
transplants themselves after being left with inadequate
liver volumes [17].
Recipient selection is another critical factor to be
considered when deciding on whether to transplant a
partial graft with the associated higher risk of failure or
dysfunction. A balance must be struck between the risk of
transplanting the graft and the risk that the patient will
deteriorate on the waiting list. This dilemma can be
framed in the context of whether one considers the best
outcome for an individual recipient or the best use of the
graft. Generally, patients with lower MELD (Model for
End-Stage Liver Disease) scores have better outcomes,
especially with the use of marginal, live donor, or split
grafts as they can tolerate initial graft dysfunction better.
However, by definition, those with higher scores are
those more urgently in need of grafting, and despite the
higher risk of graft dysfunction and failure, the benefit to
the recipient may be greater [18,19]. The donor shortage
in liver transplantation has led not only to surgical
innovations to expand the donor pool but also to
complex ethical issues surrounding patient selection,
marginal organ donation, and liver donation, and future
work needs to focus on optimising outcomes for patients
while making the best use of the scarce donor resource.
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